Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial
about
Adjunctive therapies for AIDS dementia complexInflammation in depression: is adiposity a cause?Clinical Trials in Neurovirology: Successes, Challenges, and PitfallsEvidence-based treatment for HIV-associated dementia and cognitive impairment: why so little?The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patientsHIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depressionNeurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients.Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange programAntiretroviral therapy and central nervous system HIV type 1 infectionShould antiretroviral therapy for HIV infection be tailored for intracerebral penetration?HIV-associated neurological disorders: a guide to pharmacotherapy.Update on HIV dementia and HIV-associated neurocognitive disorders.HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.Beta2-microglobulin as a diagnostic marker in cerebrospinal fluid: a follow-up study.The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse modelBritish HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015
P2860
Q24242140-E2A36BF4-2F3F-4F4D-8159-2CFADBE8C70DQ24635451-DBE6FDFB-A3B6-486C-B946-71ACF15987E8Q30250271-16109D5D-2988-45F2-B8D9-2FC28CED993EQ33280776-78B1E0F7-527E-4E19-986B-856DFEFCBB56Q33797580-ABE6D56D-510F-4EDE-90AD-FC978890705AQ34037622-8DECB4A8-FC75-4A1F-B6FC-6A83BE78ED35Q34090453-19F090B4-D75F-4022-A9B2-3702D349F49DQ34629825-39E6B700-7728-439B-92C4-6C34D881AADAQ36802400-8D825530-4B34-4A19-9E06-4FCFC04FE45CQ36853897-62812D0F-395E-40A9-AE05-A8C6CA1A5F22Q37066982-9129CF8E-5D30-46C2-BA47-94294371434CQ37362071-0435FB74-0C94-4D8F-A6A5-286D3E76ADB4Q37971469-BD1A9E10-A300-43B7-AEF9-BF61EA5BFE7CQ38220991-1DE94756-0D14-40EB-ACE3-B9D8C67A82B9Q38223328-39708CD6-EBF7-477E-A27C-DF2A7B10075AQ38247035-9C796805-DA26-4956-9F14-74BB02D25CD7Q39957314-D8871135-BAA2-4C35-B44A-42D28985AF8EQ42235552-680D4F4C-F510-4C0C-A96A-949070BC46FDQ57180790-34D382BA-0037-46DA-A63A-972B344B5E4F
P2860
Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Factors in AIDS dementia compl ...... essons from the abacavir trial
@ast
Factors in AIDS dementia compl ...... essons from the abacavir trial
@en
Factors in AIDS dementia compl ...... essons from the abacavir trial
@nl
type
label
Factors in AIDS dementia compl ...... essons from the abacavir trial
@ast
Factors in AIDS dementia compl ...... essons from the abacavir trial
@en
Factors in AIDS dementia compl ...... essons from the abacavir trial
@nl
prefLabel
Factors in AIDS dementia compl ...... essons from the abacavir trial
@ast
Factors in AIDS dementia compl ...... essons from the abacavir trial
@en
Factors in AIDS dementia compl ...... essons from the abacavir trial
@nl
P2093
P2860
P1433
P1476
Factors in AIDS dementia compl ...... essons from the abacavir trial
@en
P2093
Carmen Romero
Colin Hall
David B Clifford
David Simpson
Gabriel Torres
Hamp Atkinson
Jose Catalan
Justin C Mc Arthur
Karen Marder
Mark Halman
P2860
P356
10.1371/JOURNAL.PCTR.0020013
P407
P577
2007-03-30T00:00:00Z